Affiliations 

  • 1 Department of Encephalopathy, Ankang Traditional Chinese Medicine Hospital, No. 47, Bashan East Road, Hanbin District, Ankang City, Shaanxi Province 725000, China
  • 2 Department of Functional (ECG Room), Ankang Traditional Chinese Medicine Hospital, No. 47, Bashan East Road, Hanbin District, Ankang City, Shaanxi Province 725000, China
  • 3 Operating Room, Ankang Traditional Chinese Medicine Hospital, No. 47, Bashan East Road, Hanbin District, Ankang City, Shaanxi Province 725000, China
  • 4 Institute of Nano Electronic Engineering, Universiti Malaysia Perlis, 01000 Kangar, Perlis, Malaysia
  • 5 Department of Cardiology, Ankang Traditional Chinese Medicine Hospital, No. 47, Bashan East Road, Hanbin District, Ankang City, Shaanxi Province 725000, China
J Anal Methods Chem, 2019;2019:6097375.
PMID: 31534814 DOI: 10.1155/2019/6097375

Abstract

Every year, over 200 million adults are undergoing noncardiac surgery. These noncardiac surgery patients may face the risk of cardiac mortality and morbidity during the perioperative and recovery periods. Around ten million patients who underwent noncardiac surgery experience cardiac complications within the first 30 days of the postoperative period; the complications are myocardial infarction, cardiac death, and cardiac arrest. This cardiovascular risk is mostly faced by the patients having cerebrovascular or cardiac disease and the patients with the age greater than 50 years. Monitoring and treating cardiac diseases with a suitable biomarker during the perioperative period is necessary for the early recovery of noncardiac surgery patients. This review discussed the risk factors and the key guidelines to avoid the cardiovascular risks during the perioperative period of noncardiac surgery patients. In addition, the biomarkers and identification strategies for cardiac diseases are discussed.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.